Israel National NewsNews BriefsPfizer sued for patent infringement in Paxlovid development Pfizer sued for patent infringement in Paxlovid development Jun 22, 2022, 8:57 PM (GMT+3)Pfizer accused of "willfull and deliberate" violation, using other company's protease inhibitor. Read moreFound a mistake? Contact usYou may like